UB-421 SC(dB4C7C22-6 mAb)
UBP-A122-HIV
Phase 1 mab completed
Quick answer
UB-421 SC(dB4C7C22-6 mAb) for HIV-1 Infection is a Phase 1 program (mab) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- HIV-1 Infection
- Phase
- Phase 1
- Modality
- mab
- Status
- completed